Novartis Ag annual gross margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Novartis Ag Gross Margin Growth & History (NVS)
Novartis Ag's gross margin was 78.81% for fiscal 2025.
View full Novartis Ag company overviewNovartis Ag annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 78.81% | +1.51 pp |
| 2024 | 2024-12-31 | 77.30% | +2.06 pp |
| 2023 | 2023-12-31 | 75.24% | −0.29 pp |
| 2022 | 2022-12-31 | 75.53% | +0.17 pp |
| 2021 | 2021-12-31 | 75.36% | +3.89 pp |
| 2020 | 2020-12-31 | 71.47% | −0.64 pp |
| 2019 | 2019-12-31 | 72.11% | +1.65 pp |
| 2018 | 2018-12-31 | 70.46% | +0.21 pp |
| 2017 | 2018-01-01 | 70.25% | +4.46 pp |
| 2016 | 2016-12-31 | 65.78% | — |
Novartis Ag quarterly gross margin
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | 81.93% | +9.53 pp |
| Q2 2024 | 2024-06-30 | 77.52% | +5.31 pp |
| Q2 2023 | 2023-06-30 | 73.47% | +0.21 pp |
| Q2 2022 | 2022-06-30 | 73.03% | +1.77 pp |
| Q2 2021 | 2021-06-30 | 72.40% | +5.12 pp |
| Q2 2020 | 2020-06-30 | 72.20% | — |
| Q2 2019 | 2019-06-30 | 73.26% | — |
| Q2 2018 | 2018-06-30 | 71.27% | — |
| Q2 2017 | 2017-06-30 | 67.28% | — |
Novartis Ag gross margin trends
Over the last five reported fiscal years, Novartis Ag's gross margin increased from 71.47% to 78.81%, a change of +7.34 percentage points. The latest reported quarter, Q2 2025, shows 81.93%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novartis Ag filings at SEC.gov ↗